Obayashi to Acquire Multiplex in $526M Expansion Deal 
Qantas Nears Launch of World’s Longest Non-Stop Flights to London and New York 
Ukrainian Drone Makers Target Japan and Asia Defense Market 
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation 
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples 
Frank Stronach Found Guilty of Sexual Assault and Indecent Assault in Ontario Court 
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race 
SoftBank Shares Drop as OpenAI Losses and Rising Costs Spark Investor Concerns 
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million 
Microsoft Taps AWS to Support GitHub Amid AI Coding Boom 
BHP Shares Fall as Jansen Potash Project Costs Surge 
Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business 
SpaceX Stock Slides After IPO Rally as Valuation Concerns Grow 
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 
Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions 
G7 Explores AI Access Deal With U.S. Amid Anthropic Restrictions 
Dublin, Jan. 13, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/5mpv9n/hemoglobin_a1c) has announced the addition of the "Hemoglobin A1c Testing Markets" report to their offering.
Hemoglobin A1c (HbA1c) testing is the most recent major technology to have entered the diabetes testing market. As the global prevalence of diabetes mellitus continues to increase rapidly, with more than 366 million diabetics worldwide, hemoglobin A1c testing is now an essential assay in the diabetes testing repertoire. Its clinical utility and improvements in its accuracy and implementation of standardized protocols have translated into continued market growth. This report describes the specific market segment that encompasses hemoglobin A1c testing for diagnosing and monitoring diabetes.
The study reviews all of the generally accepted clinical analytical methods that are currently in use today for measuring HbA1c levels. Moreover, it examines clinical measurement devices and reagents as utilized in hospitals, clinics, doctor's offices and at-home care locations. The report also analyzes almost all of the companies known to be marketing, manufacturing or developing hemoglobin A1c testing. Detailed tables and charts with sales forecasts and market-share data are also included.
Companies Mentioned
- Abbott Laboratories
- A. Menarini Diagnostics
- Alere, Inc.
- ARKRAY USA, Inc.
- Axis-Shield Plc
- Bayer Healthcare Diagnostics
- Beckman Coulter, Inc
- Bio-Rad Laboratories, Inc.
- EKF Diagnostics
- Infopia Co., Ltd.
- Ortho Clinical Diagnostics (part of Johnson & Johnson)
- Quotient Diagnostics
- Randox Laboratories
- Roche Diagnostics
- Siemens AG
- Tosoh Bioscience, Inc.
- Trinity Biotech Plc
Key Topics Covered:
1. Overview
2. Diabetes
3. Market Analysis: Size, Growth, Share and Competitors
4. Overview of HbA1c Testing
5. HbA1c Testing Devices on the Market
6. Business Trends in HbA1c Testing
7. Regulatory Environment and Insurance Reimbursements
8. Company Profiles
For more information visit http://www.researchandmarkets.com/research/5mpv9n/hemoglobin_a1c
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Coagulation and Hemostasis Testing
